经阴道子宫黏膜下肌瘤剔除术临床疗效分析  

Analysis of Clinical Efficacy of Transvaginal Uterine Submucosal Myoma

作　　者：孙华芹 蔡慧慧[1] 丁朝霞[1] 袁靖[1] 

机构地区：[1]青岛大学附属医院妇科,山东青岛266003

出　　处：《中国继续医学教育》2016年第27期75-76,共2页China Continuing Medical Education

摘　　要：目的评价经阴道子宫黏膜下肌瘤剔除术的临床疗效及安全性。方法回顾性分析我院2012年5月～2014年1月收治的39例经宫腔镜联合B超检查确诊的子宫黏膜下肌瘤患者的临床资料,所有患者均采用经阴道子宫黏膜下肌瘤剔除术治疗,术后对患者进行随访,并对临床疗效及安全性进行评价。结果本组39例患者手术均取得成功,术后未出现阴道大出血、周围脏器损伤及感染等并发症。术后随访结果表明治愈36例（92.3%）,有效2例（5.1%）,无效1例（2.6%）,治疗总有效率为97.4%。结论经阴道子宫黏膜下肌瘤剔除术的临床疗效可靠,术后并发症少,安全性较高。Objective To evaluate the clinical efficacy and safety of transvaginal submucosal myoma of uterus. Methods Retrospective analysis of the clinical data of 39 cases diagnosed by hysteroscopy combined with B ultrasound in the diagnosis of submucosal myoma of uterus in our hospital from May 2012 to January 2014, All patients were treated with transvaginal uterine submucosal myoma, and the patients were followed up, and the clinical efficacy and safety were evaluated. Results In this group, 39 patients were successfully operated, and there were no complications such as vaginal bleeding, peripheral organ injury and infection. Postoperative follow-up results showed that 36 cases（92.3%） were cured, 2 cases were effective（5.1%）, and 1 cases（2.6%） were ineffective. The total effective rate was 97.4%. Conclusion The clinical effect of transvaginal uterine submucosal myoma is reliable, less postoperative complications and high safety.

关 键 词：子宫黏膜下肌瘤 剔除术 阴道 临床疗效 安全性 

分 类 号：R713[医药卫生—妇产科学]